"pancreatic tumor progression" trang 14 - tải miễn phí từ tailieunhanh
Long-term trends in pancreatic cancer mortality in Spain (1952–2012)

Long-term trends in pancreatic cancer mortality in Spain (1952–2012)
10    74    1
Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: A phase II study

Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: A phase II study
7    78    1
Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma

Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma
10    78    1
Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling

Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling
11    38    1
Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing firstline gemcitabine-containing therapy: Effect of performance status and comparison with other regimens

Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing firstline gemcitabine-containing therapy: Effect of performance status and comparison with other regimens
9    70    1
Study protocol for an open-label, singlearm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinoma

Study protocol for an open-label, singlearm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinoma
8    54    1
Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
10    35    1
Switch in KRAS mutational status during an unusual course of disease in a patient with advanced pancreatic adenocarcinoma: Implications for translational research

Switch in KRAS mutational status during an unusual course of disease in a patient with advanced pancreatic adenocarcinoma: Implications for translational research
5    15    1
Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells

Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells
10    52    1
Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells

Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells
12    69    1
Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations

Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations
15    38    1
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models

Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
13    36    1
The Warburg effect in human pancreatic cancer cells triggers cachexia in athymic mice carrying the cancer cells

The Warburg effect in human pancreatic cancer cells triggers cachexia in athymic mice carrying the cancer cells
12    53    1
Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles

Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles
13    46    1
A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer

A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer
9    27    1
γ-Tocotrienol induces apoptosis in pancreatic cancer cells by upregulation of ceramide synthesis and modulation of sphingolipid transport

γ-Tocotrienol induces apoptosis in pancreatic cancer cells by upregulation of ceramide synthesis and modulation of sphingolipid transport
14    32    1
Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: A propensity score matching analysis

Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: A propensity score matching analysis
9    51    1
Pancreas – A morphometrical study in large white yorkshire and Desi pigs

Pancreas – A morphometrical study in large white yorkshire and Desi pigs
5    50    1
Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells

Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells
15    63    1
Prognostic factors for survival with nabpaclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: The ANICE-PaC study

Prognostic factors for survival with nabpaclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: The ANICE-PaC study
11    68    1